Literature DB >> 25386052

Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.

Manuel Muro1, Ruth López-Hernández1, Anna Mrowiec1.   

Abstract

Many studies have demonstrated the linkage between the IBD3 region (6p21.1-23), an area which encompasses the famous human leukocyte antigen (HLA) complex, and Crohn's disease (CD) or ulcerative colitis (UC). IBD3 is the only region that meets genome-wide significance, and provides stronger evidence of the linkage than 16p13.1-16q12.2 (IBD1), the locus that contains the susceptibility gene CARD15. However, despite these findings, IBD3 susceptibility genes remain elusive and unclear due to the strong linkage disequilibrium, extensive polymorphism, and high gene density that characterize this area and also due to varying allele frequencies in populations around the world. This area presents an extremely high abundance of genes, including the classical and non-classical major histocompatibility complex (MHC) class I and II genes, and other genes, namely MHC class III genes tumor necrosis factor (TNF)-α and -β, and Hsp, whose proteins play key functions in immunological processes. To date, it is not clear which genes within the MHC family contribute to the IBD pathogenesis, although certain HLA alleles have been associated with IBD. Recent insights into the biological function of other genes encoded within the IBD3 region, such as the MHC class I chain-related (MIC) genes, have led investigators to a more comprehensive exploration of this region. MHC class I chain-related molecule A (MICA) is highly polymorphic and interacts with NKG2D, its receptor on the surface of NK, Tγδ and T CD8(+) cells. Increased expression of MICA in intestinal epithelial cells and increased expression of NKG2D in CD4(+) T cells (lamina propria) in patients with CD have also been reported. MICA alleles have also been associated with IBD, and a variation at amino acid position 129 of the α2-heavy chain domain seems to categorize MICA alleles into strong and weak binders of NKG2D receptor, thereby influencing the effector cells' function. In this regard, a relevant role of MICA-129-Val/Met single nucleotide polymorphism has recently been implicated in the pathogenesis of IBD. TNF-α and -β also play an important role in inflammatory response. In fact, IBD is commonly treated with TNF-α inhibitors. Additionally, polymorphisms of TNF-α gene are known to affect the gene expression level and particular TNF-α genotypes may influence the response of IBD patients treated with TNF-α inhibitors.

Entities:  

Keywords:  HLA; IBD3; Inflammatory bowel disease; MICA; Tumor necrosis factor

Mesh:

Substances:

Year:  2014        PMID: 25386052      PMCID: PMC4223237          DOI: 10.3748/wjg.v20.i41.15037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  99 in total

1.  A basolateral sorting motif in the MICA cytoplasmic tail.

Authors:  Hiroshi Suemizu; Mirjana Radosavljevic; Minoru Kimura; Sotaro Sadahiro; Shinichi Yoshimura; Seiamak Bahram; Hidetoshi Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  The molecular classification of the clinical manifestations of Crohn's disease.

Authors:  Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; Martin Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy.

Authors:  T R Orchard; A Dhar; J D Simmons; R Vaughan; K I Welsh; D P Jewell
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis.

Authors:  J Glas; K Martin; G Brünnler; R Kopp; C Folwaczny; E H Weiss; E D Albert
Journal:  Tissue Antigens       Date:  2001-10

5.  Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.

Authors:  David A van Heel; Irina A Udalova; Arjuna P De Silva; Dermot P McGovern; Yoshitaka Kinouchi; Jeremy Hull; Nicholas J Lench; Lon R Cardon; Alisoun H Carey; Derek P Jewell; Dominic Kwiatkowski
Journal:  Hum Mol Genet       Date:  2002-05-15       Impact factor: 6.150

6.  Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab.

Authors:  S Mascheretti; J Hampe; T Kühbacher; H Herfarth; M Krawczak; U R Fölsch; S Schreiber
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

7.  MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201.

Authors:  A Lopez-Vazquez; L Rodrigo; D Fuentes; S Riestra; C Bousoño; S Garcia-Fernandez; J Martinez-Borra; S Gonzalez; C Lopez-Larrea
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populations.

Authors:  Annette Lantermann; Jochen Hampe; Won H Kim; Trevor A Winter; Mark Kidd; Marion Nagy; Ulrich R Fölsch; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2001-12-21       Impact factor: 2.571

9.  HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.

Authors:  Seung-Jae Myung; Suk-Kyun Yang; Hwoon-Yong Jung; Hye-Sook Chang; Beom Park; Weon-Seon Hong; Jin-Ho Kim; Il Min
Journal:  Int J Colorectal Dis       Date:  2001-12-21       Impact factor: 2.571

10.  Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6.

Authors:  Sheila A Fisher; Jochen Hampe; Andrew J S Macpherson; Alastair Forbes; John E Lennard-Jones; Stefan Schreiber; Mark E Curran; Christopher G Mathew; Cathryn M Lewis
Journal:  Eur J Hum Genet       Date:  2002-04       Impact factor: 4.246

View more
  6 in total

1.  Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome?

Authors:  Manuel Muro; Anna Mrowiec
Journal:  Dig Dis Sci       Date:  2015-05       Impact factor: 3.199

Review 2.  Pharmacogenetic biomarkers of response in Crohn's disease.

Authors:  T M Linares-Pineda; M Cañadas-Garre; A Sánchez-Pozo; M Á Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2017-06-20       Impact factor: 3.550

Review 3.  Human Gut-Associated Natural Killer Cells in Health and Disease.

Authors:  Alessandro Poggi; Roberto Benelli; Roberta Venè; Delfina Costa; Nicoletta Ferrari; Francesca Tosetti; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

4.  Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease.

Authors:  Ebtissam Saleh Al-Meghaiseeb; Abdulrahman A Al-Robayan; Mulfi Mubarak Al-Otaibi; Misbahul Arfin; Abdulrahman K Al-Asmari
Journal:  J Inflamm Res       Date:  2016-06-17

5.  The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells.

Authors:  Iolanda Agliata; Nora Fernandez-Jimenez; Chloe Goldsmith; Julien C Marie; Jose R Bilbao; Robert Dante; Hector Hernandez-Vargas
Journal:  Epigenetics       Date:  2020-04-12       Impact factor: 4.528

Review 6.  Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review.

Authors:  Rita Lauro; Federica Mannino; Natasha Irrera; Francesco Squadrito; Domenica Altavilla; Giovanni Squadrito; Giovanni Pallio; Alessandra Bitto
Journal:  Biomedicines       Date:  2021-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.